RSS   Newsletter   Contact   Advertise with us

Thermo Fisher Scientific and CSL enter strategic partnership

Christian Fernsby ▼ | May 27, 2020
Thermo Fisher Scientific and CSL announced they have entered into a strategic partnership to help meet the growing demand for biologic therapies.
Thermo Fisher Scientific
CSL   Thermo Fisher will support CSL's product portfolio
Thermo Fisher will support CSL's product portfolio by leveraging its pharma services network, including drug product development, biologics manufacturing, sterile fill finish, packaging and clinical trials logistics.

Topics: Thermo Fisher Scientific

Through a long term lease agreement with CSL, Thermo Fisher will operate a new state of the art biologics manufacturing facility in Lengnau, Switzerland, when construction is completed in mid 2021.

Within the Lengnau site, Thermo Fisher will support manufacturing of CSL's next-generation product for hemophilia patients. The site will feature highly flexible bioproduction technologies, including single-use and stainless steel, to provide a pathway from development to large-scale production as customers' needs increase. Over time, Thermo Fisher plans to expand the use of the site to include additional biopharma customers.